All explainers
Every published explainer, newest first. Filter by topic or section.

Can Antibiotics Treat Ulcerative Colitis? What a Cochrane Review Found
Researchers pooled data from multiple randomised trials to test whether antibiotics can help with UC remission. The findings are cautiously promising, but come with important caveats.

Why Crohn's Disease Is More Likely to Cause Anaemia Than Ulcerative Colitis: What a 2026 Systematic Review Found
A 2026 systematic review published in the International Journal of Molecular Sciences examined why anaemia is more prevalent in Crohn's disease than in ulcerative colitis, identifying the key molecular and physiological mechanisms that drive the difference.

Vaccines and IBD: What the Guidelines Say About Timing Around Biologics and Immunosuppression
For people with inflammatory bowel disease on immunosuppressive treatment, vaccination is a planned, timing-sensitive part of care. International guidelines agree on a few clear principles: sort out vaccines early, give live vaccines before treatment where possible, and rely on inactivated vaccines once treatment has started.

Negative-Pressure Wound Dressings After Stoma Reversal: What Seven Randomised Trials Found
A 2026 GRADE-based systematic review and meta-analysis of seven randomised controlled trials compared negative-pressure wound therapy (NPWT) with conventional dressings after stoma reversal surgery, examining surgical site infection rates and healing outcomes.

Anti-TNF Drugs for Children With Crohn's Disease: What a 2025 Cochrane Systematic Review Found
A 2025 Cochrane systematic review examined the randomised controlled trial evidence on tumour necrosis factor-alpha antagonists, including infliximab and adalimumab, for treating Crohn's disease in children and adolescents, a population in which treatment decisions carry particular weight given the needs of a developing body.

Which Biologic Medicines Help Crohn's Disease Remission? A 2026 Cochrane Network Review Compares Them All
A 2026 systematic review and network meta-analysis in the Cochrane Database of Systematic Reviews examined the full range of biologic and advanced therapies for inducing and maintaining remission in Crohn's disease, providing the most comprehensive head-to-head evidence comparison to date.

Can IBD Affect Memory and Thinking? A 2026 Systematic Review of 66 Studies Investigates
A systematic review published in the Journal of Crohn's & Colitis in May 2026 searched PubMed and Scopus through August 2024, analysing 66 studies from population research, genetic investigations, and preclinical models, and found that patients with IBD may exhibit impaired cognitive function, particularly in memory, attention, and executive processing, with disease activity, chronic inflammation, and psychological stress among the contributing factors identified.

Wound Healing After Stoma Reversal: What a 2024 Cochrane Review Found
A 2024 Cochrane systematic review and meta-analysis compared two techniques for closing the skin wound after stoma reversal and found that one approach was associated with a significantly lower rate of surgical site infection.

Skin Problems Around the Stoma: What a 2026 Systematic Review Found About Who Is at Risk
A 2026 systematic review and meta-analysis in Frontiers in Medicine examined risk prediction models for moisture-associated skin damage in the peristomal area, identifying the factors most consistently linked to skin breakdown in people living with a stoma.

Stigma After Stoma Surgery: What a 2026 Evidence Review Found About Screening and Support
A 2026 literature review in Frontiers in Oncology identified approaches to detecting felt stigma in colorectal cancer patients with stomas and summarised evidence on which interventions provide meaningful support.

The Gut-Brain Axis in IBD: What a 2026 Systematic Review of 1,040 Patients Found About Microbiota and Mood
A systematic review published in Frontiers in Microbiology in June 2026 analysed ten studies involving 1,040 IBD patients and found that anxiety and depressive symptoms were associated with reduced gut microbial diversity and enrichment of pro-inflammatory bacterial taxa, with authors concluding the relationship may be bidirectional.

Beyond the Bowel: What a 2025 Cochrane Review Found About Psychological Interventions in IBD
A 2025 Cochrane systematic review and meta-analysis by Tiles-Sar and colleagues examined the randomised trial evidence for psychological interventions in inflammatory bowel disease, assessing whether approaches such as cognitive behavioural therapy, mindfulness, and stress management affect disease activity, quality of life, and psychological wellbeing.